News
A new study finds the use of weight loss drugs like Ozempic, Wegovy, and Zepbound in people with Type-1 Diabetes has risen ...
Nerve injury, or neuropathy, affects millions globally and is difficult to treat. It often causes symptoms like tingling, ...
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.
This popular spice is beloved by many, but its potential interactions with certain medications are important to be aware of.
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
Research shows diabetes medications may cut Alzheimer's risk by up to 43% in patients with type 2 diabetes, offering ...
Food additive mixtures commonly found in diet drinks, soups, dairy desserts and sauces may slightly increase a person's risk ...
Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...
GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.
Drugs originally developed to treat type 2 diabetes, particularly GLP-1 receptor agonists such as semaglutide (sold as ...
Science Featured on MSN1d
Popular Diabetes Drug Linked to Rare Vision Loss in New StudyPeople taking a popular diabetes medication called semaglutide, sold under brand names like Ozempic, Wegovy, and Rybelsus may face a small but important risk to their vision, according to new research ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results